In this conversation, Ben Hwang, CEO of Profusa, shares his unique journey from working with the Dodgers to leading a company focused on innovative biosensors. He discusses the vision behind Profusa, the challenges of transforming healthcare through technology, and the importance of real-time data in managing chronic diseases. Hwang emphasizes the need for accessible and clinically validated health solutions and outlines the future aspirations of the company in scaling their technology to benefit a wider audience.
Profusa Website - https://profusa.com/
Nano Cap Podcast Website - https://www.nanocappod.com/
Takeaways
Ben's early experiences with the Dodgers shaped his career.
He transitioned from sports to academia, earning a PhD.
Profusa aims to revolutionize healthcare with real-time data.
The importance of clinical validation in health tech.
User experience is crucial for technology adoption.
The vision for Profusa has remained consistent over the years.
Data must be meaningful for healthcare decisions.
The company focuses on chronic disease management.
Future products will expand beyond glucose monitoring.
Accessibility of technology is a key mission for Profusa.
DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
